Angewandte Chemie International Edition · 2025 · 12 citations · 60 references
MedicineOncologyPharmacologyBioorthogonal ChemistryImmunotherapyTumor ImmunologyApoptosis In CancerCancer ImmunotherapyEndoplasmic Reticulum Stress-induced ApoptosisPhotothermal TherapyTargeted Cancer TherapyTargeted TherapyCancer Photothermal TherapyImmunogenic ApoptosisImmunogenic Cell Death InductionMolecular TargetingPhotothermal Ablation Of TumorsPhotothermal EffectsPyroptosis MechanismsTargeted Photothermal Therapy
Selective ablation of tumor cells allows safe eradication, thereby minimizing off-target damage, while specifically inducing immunogenic cell death (ICD) rather than commonly non-immunogenic apoptosis of tumor cells enables activation of anti-tumor immune response against residual cancer cells, including metastatic lesions. Herein, we present a general strategy leveraging a novel photothermal agent (PTA) that concomitantly enables precise tumor killing and activation of anti-tumor immunity. The unique PTA scaffold exhibits unexpected inherent endoplasmic reticulum (ER)-targeting capability and potent near-infrared (NIR) photothermal activity, inducing NIR-controlled immunogenic pyroptosis in various tumor cell lines via targeting ER stress in an oxygen-independent manner. Moreover, both ER-targeting and NIR-activity of our scaffold can be modulated on demand by chemical caging/uncaging, allowing quick activation with diverse biological and bioorthogonal molecular triggers. The potency of this universal platform is demonstrated via its application to develop a membrane protein-activatable NIR-agonist that selectively activates ICD in tumor sites while priming anti-tumor immunity, minimizing off-target effects and enhancing efficacy against mouse breast tumors. This versatile approach could lead to customization of various personalized and effective immune NIR-agonists for specific photoimmunotherapy applicable to diverse solid tumors.
60
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
Andrew W. Roberts, Matthew S. Davids, John M. Pagel et al. · New England Journal of Medicine · 2015 · 1.9K citations · Full text
Medicine, Cancer Biology, Oncology +14
Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition
Matthew J. Hangauer, Vasanthi S. Viswanathan, Matthew J. Ryan et al. · Nature · 2017 · 1.7K citations
Medicine, Oncology, Pharmacology +11
A bioorthogonal system reveals antitumour immune function of pyroptosis
Qinyang Wang, Yupeng Wang, Jingjin Ding et al. · Nature · 2020 · 1.1K citations
Palladium-mediated intracellular chemistry
Muhammad Rahimi Yusop, Asier Unciti‐Broceta, Emma M. Johansson et al. · Nature Chemistry · 2011 · 520 citations · Full text